Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Potential roles of gut microbiome and metabolites in modulating ALS in mice.

Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, Zabari M, Brik RB, Kviatcovsky D, Zmora N, Cohen Y, Bar N, Levi I, Amar N, Mehlman T, Brandis A, Biton I, Kuperman Y, Tsoory M, Alfahel L, Harmelin A, Schwartz M, Israelson A, Arike L, Johansson MEV, Hansson GC, Gotkine M, Segal E, Elinav E.

Nature. 2019 Aug;572(7770):474-480. doi: 10.1038/s41586-019-1443-5. Epub 2019 Jul 22.

PMID:
31330533
2.

The palmomental reflex predicts earlier corticobulbar involvement in ALS.

Arwas N, Leshno A, Gotkine M.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):513-515. doi: 10.1080/21678421.2018.1497064. Epub 2018 Oct 9.

PMID:
30299162
3.

Hope and self-efficacy are associated with better satisfaction with life in people with ALS.

Galin S, Heruti I, Barak N, Gotkine M.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):611-618. doi: 10.1080/21678421.2018.1476546. Epub 2018 May 31.

PMID:
29848125
4.

Reconsidering the causality of TIA1 mutations in ALS.

van der Spek RA, van Rheenen W, Pulit SL, Kenna KP, Ticozzi N, Kooyman M, Mclaughlin RL, Moisse M, van Eijk KR, van Vugt JJFA, Iacoangeli A, Andersen P, Nazli Basak A, Blair I, de Carvalho M, Chio A, Corcia P, Couratier P, Drory VE, Glass JD, Hardiman O, Mora JS, Morrison KE, Mitne-Neto M, Robberecht W, Shaw PJ, Panad├ęs MP, van Damme P, Silani V, Gotkine M, Weber M, van Es MA, Landers JE, Al-Chalabi A, van den Berg LH, Veldink JH; PROJECT MINE ALS SEQUENCING CONSORTIUM.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):1-3. doi: 10.1080/21678421.2017.1413118. Epub 2017 Dec 13. No abstract available. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):161.

5.

Selective Unidirectional Horizontal Saccadic Paralysis From Acute Ipsilateral Pontine Stroke: Response.

Kruger JM, Sanchez JM, Eliahou R, Gotkine M.

J Neuroophthalmol. 2017 Sep;37(3):347. doi: 10.1097/WNO.0000000000000488. No abstract available.

PMID:
28107254
6.

Marked Differences in C9orf72 Methylation Status and Isoform Expression between C9/ALS Human Embryonic and Induced Pluripotent Stem Cells.

Cohen-Hadad Y, Altarescu G, Eldar-Geva T, Levi-Lahad E, Zhang M, Rogaeva E, Gotkine M, Bartok O, Ashwal-Fluss R, Kadener S, Epsztejn-Litman S, Eiges R.

Stem Cell Reports. 2016 Nov 8;7(5):927-940. doi: 10.1016/j.stemcr.2016.09.011. Epub 2016 Oct 20.

7.

Using Advanced Imaging Methods to Study Neurolathyrism.

Bick AS, Meiner Z, Gotkine M, Levin N.

Isr Med Assoc J. 2016 Jun;18(6):341-5.

8.

Cameraman's Foot.

Rosenberg S, Gomori JM, Reches A, Gotkine M.

Isr Med Assoc J. 2015 Dec;17(12):789. No abstract available.

9.

Relative preservation of finger flexion in amyotrophic lateral sclerosis.

Shemesh A, Arkadir D, Gotkine M.

J Neurol Sci. 2016 Feb 15;361:128-30. doi: 10.1016/j.jns.2015.12.028. Epub 2015 Dec 21.

PMID:
26810529
10.

Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.

Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D.

JAMA Neurol. 2016 Mar;73(3):337-44. doi: 10.1001/jamaneurol.2015.4321.

PMID:
26751635
11.

Corrigendum to "Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice".

Gotkine M, Rozenstein L, Einstein O, Abramsky O, Argov Z, Rosenmann H.

Biomed Res Int. 2015;2015:651934. doi: 10.1155/2015/651934. Epub 2015 Feb 3.

12.

Dynamic MRI testing of the cervical spine has prognostic significance in patients with progressive upper-limb distal weakness and atrophy.

Gotkine M, Abraham A, Drory VE, Argov Z, Gomori JM, Blumen SC.

J Neurol Sci. 2014 Oct 15;345(1-2):168-71. doi: 10.1016/j.jns.2014.07.034. Epub 2014 Jul 19.

PMID:
25085761
13.

Triathletes are over-represented in a population of patients with ALS.

Gotkine M, Friedlander Y, Hochner H.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):534-6. doi: 10.3109/21678421.2014.932383. Epub 2014 Jul 10.

PMID:
25007701
15.

Rare combination of myasthenia and motor neuronopathy, responsive to Msc-Ntf stem cell therapy.

Petrou P, Argov A, Lennon VA, Gotkine M, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D.

Muscle Nerve. 2014 Mar;49(3):455-7. doi: 10.1002/mus.24143. Epub 2014 Jan 20. No abstract available.

PMID:
24327321
16.

Effect of neck flexion on somatosensory and motor evoked potentials in Hirayama disease.

Abraham A, Gotkine M, Drory VE, Blumen SC.

J Neurol Sci. 2013 Nov 15;334(1-2):102-5. doi: 10.1016/j.jns.2013.07.2519. Epub 2013 Aug 7.

PMID:
23962698
17.

Central nervous system vasculitis.

Gotkine M, Vaknin-Dembinsky A.

Curr Treat Options Neurol. 2013 Jun;15(3):367-74. doi: 10.1007/s11940-013-0227-8.

PMID:
23475760
18.

Neurologic manifestations of systemic immunopathological diseases.

Gotkine M, Vaknin-Dembinsky A.

Curr Treat Options Neurol. 2012 Jun;14(3):276-92. doi: 10.1007/s11940-012-0171-z.

PMID:
22399412
19.

Hypnotic relaxation vs amitriptyline for tension-type headache: let the patient choose.

Ezra Y, Gotkine M, Goldman S, Adahan HM, Ben-Hur T.

Headache. 2012 May;52(5):785-91. doi: 10.1111/j.1526-4610.2011.02055.x. Epub 2011 Dec 21.

PMID:
22188357
20.

Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?

Vaknin-Dembinsky A, Abramsky O, Petrou P, Ben-Hur T, Gotkine M, Brill L, Brenner T, Argov Z, Karussis D.

Arch Neurol. 2011 Dec;68(12):1557-61. doi: 10.1001/archneurol.2011.200. Epub 2011 Aug 8.

PMID:
21825214
21.

Limbic encephalitis presenting as a post-partum psychiatric condition.

Gotkine M, Ben-Hur T, Vincent A, Vaknin-Dembinsky A.

J Neurol Sci. 2011 Sep 15;308(1-2):152-4. doi: 10.1016/j.jns.2011.06.017. Epub 2011 Jun 25.

PMID:
21705029
22.

Post infectious CNS disorders: towards a unified approach.

Gotkine M, Kennedy PG, Steiner I.

J Neurol. 2010 Dec;257(12):1963-9. doi: 10.1007/s00415-010-5743-9. Epub 2010 Sep 21. Review.

PMID:
20857134
23.

Education research: assessment of neurology resident clinical competencies in the neurology clinic.

Gotkine M.

Neurology. 2009 Sep 22;73(12):998-9; author reply 999. doi: 10.1212/WNL.0b013e3181b26a2e. No abstract available.

PMID:
19770481
24.

Neuromyelitis optica and the Optic Neuritis Treatment Trial.

Gotkine M.

Arch Neurol. 2008 Nov;65(11):1545-6; author reply 1546. doi: 10.1001/archneur.65.11.1545-c. No abstract available.

PMID:
19001178
25.

Rating the approachability of faces in ALS.

Gotkine M.

Neurology. 2008 Aug 26;71(9):696; author reply 696. doi: 10.1212/01.wnl.0000325483.54066.b1. No abstract available.

PMID:
18725600
26.

Increased severity over generations of Charcot-Marie-Tooth disease type 1A.

Steiner I, Gotkine M, Steiner-Birmanns B, Biran I, Silverstein S, Abeliovich D, Argov Z, Wirguin I.

J Neurol. 2008 Jun;255(6):813-9. doi: 10.1007/s00415-008-0693-1. Epub 2008 Apr 30.

PMID:
18438698
27.

Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.

Eichel R, Meiner Z, Abramsky O, Gotkine M.

Arch Neurol. 2008 Feb;65(2):267-71. doi: 10.1001/archneurol.2007.59.

PMID:
18268199
28.

Re: Recanalization after intravenous thrombolysis: does a recanalization time window exist?

Gotkine M, Rosenberg G, Steiner I.

Neurology. 2008 Jan 29;70(5):406; author reply 406-7. doi: 10.1212/01.wnl.0000304032.77813.18. No abstract available.

PMID:
18227425
29.

The protective effect of risk factors against stroke severity.

Steiner I, Gotkine M, Wirguin I.

J Neurol Sci. 2008 Apr 15;267(1-2):187-8. No abstract available.

PMID:
18068188
30.

Clinical differentiation between primary lateral sclerosis and upper motor neuron predominant amyotrophic lateral sclerosis.

Gotkine M, Argov Z.

Arch Neurol. 2007 Oct;64(10):1545; author reply 1545. No abstract available.

PMID:
17923644
31.

Hemipseudoathetosis due to a hemorrhage at the cervicomedullary junction.

Gotkine M, Gomori JM.

Neurology. 2007 Oct 9;69(15):1551. No abstract available.

PMID:
17923617
32.

Rifampicin-induced CYP3A4 activation in CTX patients cannot replace chenodeoxycholic acid treatment.

Szalat A, Gershkovich P, Ben-Ari A, Shaish A, Liberman Y, Boutboul E, Gotkine M, Hoffman A, Harats D, Leitersdorf E, Meiner V.

Biochim Biophys Acta. 2007 Jul;1771(7):839-44. Epub 2007 May 1.

PMID:
17553741
33.

Vascular risk factors and cognitive decline among elderly male twins.

Gotkine M.

Neurology. 2007 May 22;68(21):1871; author reply 1871. No abstract available.

PMID:
17515556
34.

Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity.

Gotkine M, Steiner I.

Neurology. 2007 Apr 3;68(14):1162; author reply 1162-3. No abstract available.

PMID:
17404206
35.

Probable medication-overuse headache: the effect of a 2-month drug-free period.

Gotkine M.

Neurology. 2007 Feb 13;68(7):536; author reply 536. No abstract available.

PMID:
17296926
36.

Now dear, I have a headache! Immediate improvement of cluster headaches after sexual activity.

Gotkine M, Steiner I, Biran I.

J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1296. No abstract available.

37.

Occurrence of CNS demyelinating disease in patients with myasthenia gravis.

Gotkine M, Fellig Y, Abramsky O.

Neurology. 2006 Sep 12;67(5):881-3.

PMID:
16966558
38.

Lack of hemispheric localizing value of the palmomental reflex.

Gotkine M, Haggiag S, Abramsky O, Biran I.

Neurology. 2005 May 10;64(9):1656. No abstract available.

PMID:
15883341
39.

Emergent stenting to treat patients with carotid artery dissection: clinically and radiologically directed therapeutic decision making.

Cohen JE, Leker RR, Gotkine M, Gomori M, Ben-Hur T.

Stroke. 2003 Dec;34(12):e254-7. Epub 2003 Nov 6.

PMID:
14605318

Supplemental Content

Loading ...
Support Center